CODX
HEALTHCARECo-Diagnostics, Inc. Common Stock
AI Insight
What's Moving CODX Today?
No stock-specific AI insight has been generated for CODX yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.26$46.50
$3.23
Fundamentals
Market Cap$12M
P/E Ratio—
EPS$-33.04
Dividend Yield—
Dividend / Share—
ROE-151.7%
Profit Margin—
Debt / Equity—
Trading
Volume339K
Avg Volume (10D)—
Shares Outstanding3.7M
CODX News
22 articles- Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing LineYahoo Finance·Jun 18, 2026
- Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor AgreementYahoo Finance·Jun 11, 2026
- Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform CapabilitiesYahoo Finance·Jun 2, 2026
- Is Co-Diagnostics National Security’s Next Diagnostic Pick?Marketbeat·May 28, 2026
- Co-Diagnostics (CODX) Q4 2025 Earnings TranscriptMotley Fool·May 27, 2026
- Top Midday GainersYahoo Finance·May 26, 2026
- CODX Stock Explodes Over 630% In Six Sessions – Retail Traders Bet The Rally Isn’t Over YetStocktwits·May 26, 2026
- Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSaraYahoo Finance·May 26, 2026
- Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq RulesYahoo Finance·May 20, 2026
- Co-Diagnostics Develops Ebola Assay Strategy Following WHO Emergency Alert (CODX)Advfn·May 19, 2026
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak AlertYahoo Finance·May 19, 2026
- Co-Diagnostics (CODX) Q1 2026 Earnings TranscriptMotley Fool·May 15, 2026
- Co-Diagnostics, Inc. Q1 2026 Earnings Call SummaryMoby·May 15, 2026
- Co-Diagnostics Inc (CODX) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial ...Yahoo Finance·May 15, 2026
- Co-Diagnostics Reports First Quarter 2026 Financial ResultsYahoo Finance·May 14, 2026
- CoMira concludes lease agreement for plant in Sudair Industrial City, Saudi ArabiaMedicaldevice-network·May 11, 2026
- Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial CityYahoo Finance·May 8, 2026
- GoodRx Holdings, Inc. (GDRX) Q1 Earnings Match EstimatesYahoo Finance·May 6, 2026
- Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and WebcastYahoo Finance·Apr 30, 2026
- Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.Yahoo Finance·Apr 16, 2026
- Co-Diagnostics Reports Full Year 2025 Financial ResultsBenzinga·Mar 31, 2026
- Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health OrganizationBenzinga·Mar 25, 2026
All 22 articles loaded
Price Data
Open$3.03
Previous Close$3.12
Day High$3.51
Day Low$2.97
52 Week High$46.50
52 Week Low$1.26
52-Week Range
$1.26$46.50
$3.23
Fundamentals
Market Cap$12M
P/E Ratio—
EPS$-33.04
Dividend Yield—
Dividend / Share—
ROE-151.7%
Profit Margin—
Debt / Equity—
Trading
Volume339K
Avg Volume (10D)—
Shares Outstanding3.7M
About Co-Diagnostics, Inc. Common Stock
Co-Diagnostics, Inc., a molecular diagnostic company, develops, manufactures, and sells reagents used for diagnostic tests that function by detecting and / or analyzing nucleic acid molecules. The company is headquartered in Salt Lake City, Utah.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—